EUVIMEDEUVIMED entdecken
Crossref

A Kinetic Model for Assessing Potential Nitrosamine Carcinogenicity

Shu Yu iD, J Christopher McWilliams, Olivier Dirat iD, Krista L Dobo iD, Amit S Kalgutkar iD, Michelle O Kenyon, Matthew T Martin, Eric D Watt, Maik Schuler

Chemical Research in Toxicology · 2024

DOI: 10.1021/acs.chemrestox.4c00133 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Research in Toxicology, 2024. Verfasst von Shu Yu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Chemical Research and Development, Pfizer Research & Development, Groton, Connecticut 06340, United States. Hauptthemen laut MEDLINE: Nitrosamines, Carcinogens. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 51 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Understanding the potential carcinogenic potency of nitrosamines is necessary to setting acceptable intake limits. Nitrosamines and the components that can form them are commonly present in food, water, cosmetics, and tobacco. The recent observation of nitrosamines in pharmaceuticals highlighted the need for effective methods to determine acceptable intake limits. Herein, we describe two computational models that utilize properties based upon quantum mechanical calculations in conjunction with mechanistic insights and established data to determine the carcinogenic potency of a variety of common nitrosamines. These models can be applied to experimentally untested nitrosamines to aid in the establishment of acceptable intake limits.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NitrosaminesCarcinogensKineticsHumansCarcinogenicity TestsQuantum Theory

Substanzen

NitrosaminesCarcinogens

Autor:innen und Institutionen

  • Chemical Research and Development, Pfizer Research & Development, Groton, Connecticut 06340, United States.
  • CMC Advisory Office, Pfizer Global Regulatory Sciences, Sandwich CT13 9NJ, U.K.
  • Drug Safety Research and Development, Pfizer Research & Development-Groton Laboratories, Groton, Connecticut 06340, United States.
  • Pharmacokinetics Dynamics and Metabolism, Pfizer Research & Development, Cambridge, Massachusetts 02139, United States.

ORCID-Profile: Shu Yu, Olivier Dirat, Krista L Dobo, Amit S Kalgutkar

Zitieren

APA

Yu, S., McWilliams, J. C., Dirat, O., Dobo, K. L., Kalgutkar, A. S., Kenyon, M. O., Martin, M. T., Watt, E. D., & Schuler, M. (2024). A Kinetic Model for Assessing Potential Nitrosamine Carcinogenicity. Chemical Research in Toxicology. https://doi.org/10.1021/acs.chemrestox.4c00133

Vancouver

Yu S, McWilliams JC, Dirat O, Dobo KL, Kalgutkar AS, Kenyon MO, et al. A Kinetic Model for Assessing Potential Nitrosamine Carcinogenicity. Chemical Research in Toxicology. 2024. doi:10.1021/acs.chemrestox.4c00133

BibTeX
@article{Yu2024,
  author = {Yu, Shu and McWilliams, J Christopher and Dirat, Olivier and Dobo, Krista L and Kalgutkar, Amit S and Kenyon, Michelle O and Martin, Matthew T and Watt, Eric D and Schuler, Maik},
  title = {A Kinetic Model for Assessing Potential Nitrosamine Carcinogenicity},
  journal = {Chemical Research in Toxicology},
  year = {2024},
  doi = {10.1021/acs.chemrestox.4c00133}
}
Kostenlos starten →